Last updated 44 days ago
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
6200 patients around the world
Available in Argentina, Mexico, United States, Brazil, Spain
Novo Nordisk A/S
21Research sites
6200Patients around the world
This study is for people with
Cardiovascular disease
Renal disease
Chronic kidney disease
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
CER Instituto Médico - Quilmes, Buenos Aires
Recruiting
CEMIC - Hospital Universitario Sede Saavedra - CABA, Buenos Aires
Recruiting
Instituto de Investigaciones Clínicas San Nicolás
Recruiting
ICBA Instituto Cardiovascular de Buenos Aires
Recruiting
Centro Especialidades Médicas SRL (CEMEDIC)
Recruiting
Investigación Clínica Aplicada S.R.L.
Recruiting
Centro Médico Lebensohn
Recruiting
Hospital Italiano de La Plata
Recruiting
Centro de Investigación Cardiometabólica de Aguascalientes, S.C.
Recruiting
FAICIC Clinical Research
Recruiting
StudyZEUS
SponsorNovo Nordisk A/S
Study typeInterventional
Conditions
Chronic kidney disease
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05021835
